In high-risk outpatients with COVID-19, remdesivir reduced COVID-19-related hospitalization or all-cause death at 28 d.
Where this comes from
- Record sourced from PubMed, PMID 35500263.
- Also identified by DOI 10.7326/J22-0026.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Gottlieb RL, Vaca CE, Paredes R, et al. <b>Early remdesivir to prevent progression to severe Covid-19 in outpatients.</b> N Engl J Med. 2022;386:305-15. 34937145.
Medical subject headings
- Adenosine Monophosphate
- Alanine
- COVID-19 Drug Treatment